ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature (1999) The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis and Rheumatism; 42: 599–608.
Appenzeller, S, Cendes, F, Castallat, L (2008) Acute psychosis in systemic lupus erythematosus. Rheumatology International; 28: 237–43.
Arnett, FC, Reveille, JD, Moutsopoulos, HM et al (1996) Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis and Rheumatism; 39: 1833–9.
Baca, V, Lavalle, C, García, R et al (1999) Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. Journal of Rheumatology; 26: 432–9.
Bodani, M, Kopelman, MD (2003) A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus. Lupus; 12: 947–9.
Brey, RL, Holliday, SL, Saklad, AR et al (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology; 58: 1214–20.
Cassis, TB, Callen, JP (2005) Bupropion-induced subacute cutaneous lupus erythematosus. Australasian Journal of Dermatology; 46: 266–9.
Ditmore, BG, Malek-Ahmadi, P, Millis, DM et al (1992) Manic psychosis and catatonia stemming from systemic lupus erythematosus: response to ECT. Convulsive Therapy; 8: 33–7.
Douglas, CJ, Schwartz, HI (1982) ECT for depression caused by lupus cerebritis: a case report. American Journal of Psychiatry; 139: 1631–2.
Driver, CB, Wallace, DJ, Lee, JC et al (2008) Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus. Arthritis and Rheumatism (Arthritis Care & Research); 59: 332–7.
Emmer, BJ, Steup-Beekman, GM, Steens, SC et al (2008) Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction. Arthritis and Rheumatism; 58: 1451–7.
Fallon, BA, Liebowitz, MR (1991) Fluoxetine and extrapyramidal symptoms in CNS lupus. Journal of Clinical Psychopharmacology; 11: 147–8.
Fernandez, G, Gorriti, M, Garcia-Vicuna, R et al (2007) Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report. Rheumatology International; 27: 883–5.
Garety, PA, Kuipers, L, Fowler, D et al (1994) Cognitive behavioural therapy for drug resistant psychosis. British Journal of Medical Psychology; 67: 259–71.
George-Chandy, A, Trysberg, E, Eriksson, K (2008) Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Research and Therapy; 10: R97.
Goldberg, D, Huxley, P (1992) Common Mental Disorders. Routledge.
Harth, Y, Rapoport, M (1996) Photosensitivity associated with antipsychotics, antidepressants and anxiolytics. Drug Safety; 14: 252–9.
Hanly, JG, Harrison, MJ (2005) Management of neuropsychiatric lupus. Best Practice and Research Clinical Rheumatology; 19: 799–821.
Herrmann, N, Lanctôt, KL (2005) Do atypical antipsychotics cause stroke?
Central Nervous System Drugs; 19: 91–103.
Hill, VA, Hepburn, NC (1998) Sertraline associated discoid lupus erythematosus-like eruption. Journal of the Royal Army Medical Corps; 144: 109–10.
Hughes, M, Sundgren, PC, Fan, X et al (2007) Diffusion tensor imaging in patients with acute onset of neuropsychiatric systemic lupus erythematosus: a prospective study of apparent diffusion coefficient, fractional anisotropy values, and eigen values in different regions of the brain. Acta Radiologica; 48: 213–22.
Jentsch, JD, Roth, RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology; 20: 201–25.
Kozora, E, Arciniegas, D, Zhang, L et al (2007) Neuropsychological patterns in systemic lupus erythematosus patients with depression. Arthritis Research and Therapy; 9: R48.
Krupp, LB, LaRocca, NG, Muir, J et al (1990) A study of fatigue in systemic lupus erythematosus. Journal of Rheumatology; 17: 1450–2.
Kuipers, E, Garety, P, Fowler, D et al (1997) London–East Anglia randomised controlled trial of cognitive–behavioural therapy for psychosis. I: effects of treatment phase. British Journal of Psychiatry; 171: 319–27.
Lapteva, L, Nowak, M, Yarboro, CH et al (2006) Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systematic lupus erythematosus. Arthritis and Rheumatism; 54: 2505–14.
Lipton, SA, Rosenberg, PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New England Journal of Medicine; 330: 613–22.
Mak, A, Mok, CC, Chu, WP et al (2007a) Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. Lupus; 16: 28–34.
Mak, A, Chan, BP, Yeh, IB et al (2007b) Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma. Rheumatology; 47: 256–62.
Maes, M, Meltzer, HY, Bosmans, E et al (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorder; 34: 301–9.
McKinley, P, Ouellette, SC, Winkel, G (1995) The contributions of disease activity, sleep patterns and depression to fatigue in systemic lupus erythematosus. Arthritis and Rheumatism; 38: 826–34.
Monastero, R, Bettini, P, Del Zotto, E et al (2001) Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. Journal of Neurological Sciences; 184: 33–9.
Nishimura, K, Omori, M, Horikawa, N et al (2003) Risperidone in the treatment of acute confusional state due to neuropsychiatric lupus erythematosus: case report. International Journal of Psychiatry in Medicine; 33: 299–303.
Petri, M (2007) The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheumatic Diseases Clinics of North America; 33: 227–35.
Pollmächer, T, Haack, M, Schuld, A et al (2002) Low levels of circulating inflammatory cytokines. Do they affect human brain functions?
Brain, Behaviour, and Immunity; 16: 525–32.
Poole, JL, Atanasoff, G, Pelsor, JC et al (2006) Comparison of a self-report and performance-based test of disability in people with systemic lupus erythematosus. Disability and Rehabilitation; 28: 653–8.
Stojanovich, L, Zandman-Goddard, G, Pavlovich, S et al (2007) Psychiatric manifestations of systemic lupus erythematosus. Autoimmunity Review; 6: 421–6.
Stoll, T, Kauer, Y, Buchi, S et al (2001) Prediction of depression in systemic lupus erythematosus patients using SF–36 Mental Health scores. Rheumatology; 40: 695–8.
Su, JA, Wu, CH, Tsang, HY (2007) Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report. General Hospital Psychiatry; 29: 75–7.
Sun, XY, Shi, J, Han, L et al (2008) Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. Journal of Clinical Laboratory Analysis; 22: 271–7.
Tan, HY, Chen, Q, Sust, S et al (2007) Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proceedings of the National Academy of Sciences of the United States of America; 104: 12536–41.
Taylor, J, Skan, J, Erb, N et al (2000) Lupus patients with fatigue: is there a link with fibromyalgia syndrome?
Rheumatology; 39: 620–3.
Tench, CM, McCurdie, I, White, PD et al (2000) The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology; 39: 1249–54.
Tench, CM, McCarthy, J, McCurdie, I et al (2003) Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology; 42: 1050–4.
Tektonidou, MG, Varsou, N, Kotoulas, G et al (2006) Cognitive deficits in patients with antiphospholipid syndrome. Archives of Internal Medicine; 166: 2278–84.
Ward, MM, Marx, AS, Barry, NN (2002) Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology; 41: 184–8.
Wekking, EM (1993) Psychiatric symptoms in systemic lupus erythematosus: an update. Psychosomatic Medicine; 55: 219–28.
Welsh, RC, Rahbar, H, Foerster, B et al (2007) Brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus with new acute neurological symptoms. Journal of Magnetic Resonance Imaging; 26: 541–51.
Wolkowitz, OM, Reus, VI, Canick, J et al (1997) Glucocorticoid medication, memory and steroid psychosis in medical illness. Annals of the New York Academy of Sciences; 823: 81–96.
Wykes, T, Reeder, C, Corner, J et al (1999) The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophrenia Bulletin; 25: 291–307.
Yang, XY, Lin, J, Lu, XY et al (2008) Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus. Clinical Rheumatology; 27: 353–7.
Yoshida, A, Shishido, F, Kato, K et al (2007) Evaluation of cerebral perfusion in patients with neuropsychiatric systemic lupus erythematosus using 123I-IMP SPECT. Annals of Nuclear Medicine; 21: 151–8.
Zhang, L, Harrison, M, Heier, LA et al (2007) Diffusion changes in patients with systemic lupus erythematosus. Magnetic Resonance Imaging; 25: 399–405.